Author:
Maxey Randall W.,Williams Richard Allen
Reference49 articles.
1. Poolsup, N., Li Wan Po, A., and Knight, T. L. (2000) Pharmacogenetics and psychopharmacotherapy. J. Clin. Pharm. Ther.
25, 197–220.
2. Taylor, A. L., Ziesche, S., Yancy, C., et al. (2004) African American Heart Failure Trial. N. Engl. J. Med.
351, 2049–2057.
3. Yancy, C. W. (2000) Heart failure in African Americans: A cardiovascular engima. J. Card. Fail.
6, 183–186.
4. Rogers, W. A. (2004) Evidence based medicine and justice: A framework for looking at the impact of EBM upon vulnerable or disadvantaged groups. J. Med. Ethics
30(2), 141–145.
5. Taylor, S. E. and Braithwaite, R. L. (2001) African American Health: An Overview, in Health Issues in the Black Community, 2nd ed. (Braithwaite, R. L. and Taylor, S. E. eds.) Jossey-Bass Inc., San Francisco, p. 371.